Kymera jumps after phase Ib study data show KT-621 delivers strong STAT6 degradation and broad clinical activity in patients with atopic dermatitis.

Admissions to BHU MBA programs require CAT scores, academic records, group discussion, and personal interview with respective ...

Shares of US clinical-stage biotech Kymera Therapeutic leapt almost 33% to $88.48 pre-market, as it announced compelling early results for its first-in-class oral STAT 6 degrade KT-621.

The Chromebooks that Leon County students have been toting from school to home and back again will have to stay at school for some middle schoolers.

The junior showcased big-time scoring ability last week. He scored 25 points as Eureka lost to host Bloomington Central ...

Preliminary clinical evidence of Lisaftoclax overcoming venetoclax resistance in myeloid malignancies with a 31.8% overall ...

New courses are coming to Northwest Arkansas public high schools next year, including more career-aligned training classes.

Nominees this week included students from Adams High and NorthWood High. Check back on Monday for next week's nominees!

Overall response rate (ORR) in triple combo study with azacitidine and venetoclax in newly diagnosed AML patients80% CR and ...

China NMPA approves Antengene’ IND application for phase Ib/II study of ATG-022 in combo with Keytruda± chemotherapy: Shanghai Wednesday, December 3, 2025, 18:00 Hrs [IST] Ante ...

There are several high school classes above regulated capacity in the Kamloops-Thompson School District this fall, but staff say that's largely to the benefit of the learning environment.

R ondo Therapeutics has initiated dosing in its Phase I/Ib clinical trial of first-in-class bispecific antibody, RNDO-564, ...